Profil
James Wooldridge is currently the Chief Medical Officer at Checkmate Pharmaceuticals, Inc. He previously worked as the Chief Medical Officer at Spyre Therapeutics, Inc. from 2017 to 2019 and as the Chief Scientific Officer at Eli Lilly & Co. He received his doctorate degree from Tulane University in 1992 and his undergraduate degree from William Jewell College in 1988.
Postes actifs de James Wooldridge
| Sociétés | Poste | Début |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2019 |
Anciens postes connus de James Wooldridge
| Sociétés | Poste | Fin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 10/10/2019 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formation de James Wooldridge
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
William Jewell College
William Jewell College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
















